Objective: To assess computed tomography with volume rendering (CT-VR) as a tool to evaluate parenchymal hyperinflation before and after bronchoscopic lung volume reduction (BLVR) in patients with advanced stage emphysema. Materials and methods: Between March 2006 and October 2007, we have prospectively studied pre-and postoperatively by spiral multislice CT scan and functional tests seven patients (six male, one female; age range 51-77 years, mean 64) with advanced stage heterogeneous emphysema who underwent BLVR using the Emphasys one-way valves (Emphasys, Redwood City, CA, USA). CT parameters considered were: the volume of the 'target' lobe and of the entire treated lung, the diameters (antero-posterior and cranio-caudal) of the treated hemithorax and the emphysematous parenchyma rate with respect to the normal parenchyma rate of the treated lobe. Lung parenchyma has been classified as emphysematous if the density was in the À1024/À900 Hounsfield units (HU) range and as normal if the density was in the À900/À200 HU range. Preoperative radiological data were compared with postoperative data and plotted against spirometric data observed 1 month after treatment. Results: Overall, 24 valves have been implanted in the 7 patients. Valves have been placed in the right upper lobe in two patients, in the left upper lobe in four and in both the left upper lobe and the right lower lobe in one. Volume reduction as a proportion of the 'target' lobe and of the entire lung has been observed in all patients with significant differences between mean preoperative and postoperative values [p = 0.016 (target lobe); p = 0.031 (lung)]. Lobar volume reduction ranged between 1.3% and 53.7% of preoperative values. Volume reduction of the entire lung ranged between 3.1% and 16.8%. Thoracic diameters decreased in all patients after treatment with significant mean differences [p = 0.007 (antero-posterior); p = 0.004 (cranio-caudal)]. FEV1 increased in six of seven patients with significant mean differences ( p = 0.025). The higher volume reduction rate has been observed in the three patients showing the better FEV1 improvement. Emphysematous lung parenchyma rate decreased postoperatively in six of seven patients with mean differences being not significant ( p = 0.17). Conclusions: CT-VR is an excellent tool to confirm the efficacy of BLVR in reducing parenchymal hyperinflation. Functional advantages are proportional to the volume reduction as measured by CT-VR. #
Introduction
Although the benefit of surgical lung volume reduction (SLVR) has been clearly proven in selected groups of patients with heterogeneous emphysema, the morbidity of this procedure still remains considerable, with higher mortality in patients showing more advanced functional impairment [1] [2] [3] . For this reason a number of bronchoscopic alternatives have been recently proposed and some of them have been tested in selected clinical settings [4] [5] [6] [7] [8] [9] [10] [11] . In particular, bronchoscopic lung volume reduction (BLVR) with one-way valves has been the most studied option reaching clinical application [5] [6] [7] [8] 10] . These devices prevent air entering into the isolated emphysematous segment during inspiration and allow the venting of entrapped gas and the drainage of bronchial secretion during expiration. In theory, this will result in reducing the hyperinflation of the emphysematous parenchyma and even atelectasis, mimicking the effect of SLVR.
Preliminary results in early worldwide experiences with this technique have shown that the achievement of a significant reduction of parenchymal hyperinflation is the principal physiological condition determining functional improvement and alleviating dyspnea [5] [6] [7] [8] 10] . In recent years we have experimented with BLVR using both the first generation [8] and the second generation Emphasys endobronchial valves (EBV) (Emphasys, Redwood City, CA, USA). In order to objectively evaluate changes in lung parenchyma volumes, we have routinely included computed tomography (CT) in the preoperative and postoperative work-up of patients undergoing BLVR.
Hereby we report the results of a prospective study evaluating computed tomography with volume rendering (CT-VR) performed on seven consecutive patients treated with the second generation EBV to analyse the parenchymal hyperinflation before and after BLVR in order to compare the radiological findings with the functional results and to assess the efficacy of this procedure.
Materials and methods
Between March 2006 and October 2007, we have prospectively evaluated by computed tomography with three-dimensional volume rendering (CT-3D-VR) seven patients (six males, one female; age range 51-77 years, median 64) with advanced stage heterogeneous emphysema undergoing BLVR using the second generation (Zephyr W ) EBV (Emphasys, Redwood City, CA, USA). Patient selection criteria are reported in Table 1 . Critical selection criteria were: marked hyperinflation and heterogeneous distribution of emphysema in order to provide 'target areas' of severely diseased, functionless parenchyma. The protocol was approved by the ethical committee of the University of Rome 'La Sapienza'. Detailed informed consent was obtained from all patients. BLVR was offered to them as a new investigational procedure that possibly was an alternative to SLVR. They understood that SLVR could remain a further option, should the bronchoscopic procedure fail. All patients received optimal medical treatment at the time of inclusion and no changes were made in their medical therapy during the study period. Patients have been functionally and radiologically studied preoperatively and postoperatively. In this study, we have limited our analysis considering the radiological data obtained by preoperative and 1 month postoperative CT scan and functional data referring to FEV1 registered at the same time as the CT scan. Medical Research Council Dyspnea scores and blood gas data assessed preoperatively and 1 month postoperatively were also registered. Evaluation of changes in parenchymal hyperinflation was obtained by comparing CT-VR findings obtained preoperatively with those obtained 1 month postoperatively. CT parameters considered were: the volume of the 'target' lobe and of the entire treated lung, the diameters (anteroposterior and cranio-caudal) of the treated hemithorax and the emphysematous parenchyma rate with respect to the normal parenchyma rate of the treated lobe. CT examination has been performed using a 16 detectors multislice CT scanner (MX 8000, Philips, Eindhoven, The Netherlands). Acquisition technical parameters were: 3 mm slice thickness, 400 mm field of view (FOV), B filter, 200 mA, 120 kV, 0.75/s rotation time and 1.2 pitch. Images were reconstructed at 1 mm slice thickness. CT axial images have been analyzed by two expert thoracic radiologists and elaborated for volume rendering evaluation using a PACS system console (PACS Web Centricity V2.1, GE Healthcare technologies). Lung parenchyma has been classified as emphysematous if the density was in the À1024/À900 Hounsfield units (HU) range and as normal if the density was in the À900/À200 HU range [12] .
Comparison between CT scan postoperative results and FEV1 postoperative results has allowed us to assess if there was a correspondence between the radiological and the functional findings.
Operative techniques
The new generation (Zephyr W ) Emphasys EBV is a device incorporating a one-way valve supported by a stent-like selfexpanding retainer that secures the valve in place during respiration and all physiological conditions, including cough. This valve is provided in two sizes: the EBV 4.0 designed for bronchial lumen of 4-7 mm and the EBV 5.5 designed for bronchial lumens with diameters of 5.5-8.5 mm. All the operative procedures were performed in the operative room with the patient under conscious sedation and local anesthesia. These new generation devices are placed by flexible bronchoscopy: the valve is released under direct vision in the target bronchus by a preloaded delivery catheter advanced through a 2.8 mm operative channel of the bronchoscope.
The most hyperinflated, hypoperfused lobes were chosen in each patient as the 'target area' of lung to be treated. If the lobe showing the more evident hyperinflation did not correspond to the less perfused area of parenchyma, preference was given to the most hyperexpanded lobe.
Bronchoscopic control of the valves has been performed in all patients 1 month after treatment.
Statistical analysis
Student's paired t test was used to assess the significance of differences between mean values of the parameters measured before and after treatment. A p value of less than 0.05 was considered to indicate statistical significance.
Results
Preoperative CT-VR documented the presence of heterogeneous distribution of emphysema in all cases. In four patients the 'target' area selected for treatment was the left upper lobe. In two patients it was the right upper lobe. In one Table 2 . A reduction of the anteroposterior diameter and of the cranio-caudal diameter of the treated hemithorax has been observed in all seven patients (mean antero-posterior diameter reduction: 29.5 mm, standard error: 7.23, 95% confidence interval: 11.81-47.21; mean cranio-caudal diameter reduction: 20.9 mm, standard error: 4.57, 95% confidence interval: 9.71-32.08). Differences between preoperative and postoperative mean values were significant for both thoracic diameters ( p < 0.05). Data regarding postoperative changes in antero-posterior and cranio-caudal diameters are reported in details in Table 3 . The postoperative reduction of the emphysematous parenchyma rate has been observed at 1 month CT scan in six of seven patients ranging between 2.2% and 16.8% with the consequent increasing of normal parenchyma rate, but differences were not significant ( p = 0.17) ( Table 4 , Fig. 1 ).
FEV1 improvement was found in six of seven patients ranging between 10.1% and 28.1% of the baseline value and between 3.4% and 9.3% of the predicted value (mean FEV1 improvement: 0.147 l; standard error: 0.049; 95% confidence interval: À0.26 to À0.025). In one patient FEV1 decreased after BLVR. This patient (no. 7) was the one showing the lesser volume reduction of the target lobe (1.3%) and the entire lung (0.3%). Details of postoperative absolute (liters) and percentage variations of FEV1 are reported in Table 5 .
Preoperative and postoperative Medical Research Council Dyspnea scores are reported in Table 6 . Among the six patients showing radiological and spirometric improvement, all but one (patient no. 2) showed improved dyspnea grade.
Blood gas data (PaO 2 and PaCO 2 ) are reported in Table 7 and they did not appear in accordance with the spirometric and radiological changes observed, showing no significant Table 4 Emphysematous and normal parenchyma rates before and after BLVR.
PTS Target lobe Preoperative TC (%) Postoperative TC (%)
Emphysematous (À1024/À900 HU) Normal (À900/À200 HU) Emphysematous (À1024/À900 HU) Normal (À900/À200 HU) improvement in those patients who presented advantages in terms of FEV1 and CT findings.
Complete lobar atelectasis has been observed in no patient. Segmental atelectasis has been observed in one patient (no. 5).
The higher volume reduction rate, according to CT scan findings, has been observed in the three patients (nos. 4, 5, 6) showing the better FEV 1 improvement (>15%).
The only postoperative complication observed was the occurrence of a right pneumonia in the non-treated lobe of the patient undergoing bilateral BLVR. Complete resolution was achieved by antibiotic therapy. There was no mortality. No granulation tissue was present at fiberoptic bronchoscopy performed after 1 month. Postoperative CT scan at 1 month confirmed that all valves were correctly in place.
Discussion
Although the achievement of a significant reduction of lung hyperinflation has been clearly indicated as a crucial condition to improve respiratory function and to alleviate dyspnea in BLVR as well as in SLVR, a detailed study of changes occurring in parenchymal volume after treatment has been never reported in English literature. Our study demonstrates that CT-VR allows the exact quantification of the effects of lung volume reduction and the measurement of redistribution between emphysematous and normal parenchyma occurring after treatment. Although the series of patients is small, results obtained undoubtedly provide interesting indications to assess if the theoretical basis of these investigational procedures is confirmed by clinical evidence. Radiological analysis, in the present experience, has documented a volume reduction of both the target lobe and the entire lung in all patients, with significant differences between preoperative and postoperative values. Of course, differences appear extremely variable on a patient by patient basis and there are several anatomical and technical factors influencing this discrepancy. Presence of complete fissure, evidence of preoperative marked hyperinflation and accomplishment of a complete lobar exclusion have been indicated as the most significant conditions influencing the grade of reduction of parenchymal hyperexpansion [5] [6] [7] [8] 10] . In this study, although a subset analysis has not been performed, due to the limited statistical sample, there are several evidences confirming these data. The two patients showing the higher volume reduction of the target lobe (53.7% and 29.4%) and of the entire treated lung (18.7% and 27.2%) are also the only two treated by a complete lobar exclusion. Moreover, the patient with the more evident volume reduction of the 'target' lobe was the only one with a visibly complete accessory fissure (anterior segment of left upper lobe) at preoperative CT scan. A complete lobar Fig. 1. (a-b) CT-3D-VR images of lung parenchyma before (a) and after (b) BLVR. The reduction of the emphysematous parenchyma rate (blue) with respect to the normal parenchyma rate (red) is clearly visible after treatment. The marked parenchymal volume reduction is also visible. Although it is difficult to explain the reason for the FEV1 decrease in one patient, it could be indicative that this was the only case showing irrelevant changes in parenchymal hyperinflation after treatment at CT-VR. Conversely, the three patients with significant FEV1 improvement according to the American Thoracic Society (>15%) [13] were also those with the more evident parenchymal volume reduction. These observations further confirm both the positive and the negative predictive value of CT-VR.
Dyspnea score data observed postoperatively shows a good correspondence with the radiological and spirometric findings. The only patient, among those showing radiological and functional advantages, who did not improve his dyspnea grade was the one with the less compromised baseline respiratory condition (preoperative dyspnea grade 1), although a slight clinical benefit was referred in this case. On the contrary, blood gas values were not in accordance with changes observed at CT scan and spirometry and this result is similar to those reported in other experiences with analogue technique.
Only one patient in this series received a bilateral treatment, but he did not obtain the highest advantage in terms of parenchymal volume reduction and FEV1. This result can be explained by the occurrence of a postoperative pneumonia (the only complication observed in this series) that may have negatively influenced respiratory flow rates 1 month after treatment. Moreover this patient did not receive a complete lobar exclusion and this technical aspect could have limited the anatomical and functional advantage obtained.
In conclusion, CT-VR proved an excellent tool to confirm the efficacy of BLVR with one-way valves in reducing parenchymal hyperinflation. The functional advantages are higher when the volume reduction is more evident. Although acquired by a limited number of patients, these results provide interesting indications that prove the correspondence between anatomical and functional findings obtained with this endoscopic technique.
